To further determine the correlation between BRCA2 mutations and AURKB expression in prostate cancer patients, we collected samples from prostate cancer patients with intact and mutant BRCA2, and analyzed the AURKB level using immunohistochemistry. The gene discussed is BRCA2; the disease is prostate carcinoma.